Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
5.22
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
5.35
+0.13 (2.49%)
After-hours: Mar 6, 2026, 7:59 PM EST
Larimar Therapeutics Employees
Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.
Employees
65
Change (1Y)
23
Growth (1Y)
54.76%
Revenue / Employee
n/a
Profits / Employee
-$2,030,754
Market Cap
566.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Rigel Pharmaceuticals | 164 |
| Alpha Tau Medical | 125 |
| Ocugen | 95 |
| enGene Holdings | 82 |
| Verastem | 78 |
| Design Therapeutics | 55 |
| Fulcrum Therapeutics | 55 |
LRMR News
- 2 days ago - Larimar Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 9 days ago - Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - GlobeNewsWire
- 9 days ago - Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - GlobeNewsWire
- 9 days ago - Laminar Therapeutics Stock Is Popping Today: What's Going On? - Benzinga
- 10 days ago - Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga
- 10 days ago - Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026 - GlobeNewsWire
- 7 weeks ago - Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care - Seeking Alpha
- 7 weeks ago - Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha